Archive | Cancer in the News

Melanoma Journal Articles for April 2018

Clinical Cancer Research The Need for Neddylation: A Key to Achieving NED in Uveal Melanoma Jessica Yang, Omid Hamid and Richard D. Carvajal DOI: 10.1158/1078-0432.CCR-18-0020 Journal of Translational Medicine Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors Michael F. Gowen†, Keith M. Giles†, Danny Simpson†, Jeremy Tchack, Hua Zhou, Una Moran, Zarmeena Dawood, Anna C. Pavlick, Shaohui Hu, Melissa A. Wilson, Hua Zhong, Michelle Krogsgaard, Tomas Kirchhoff and Iman Osman Journal of Translational Medicine201816:82 https://doi.org/10.1186/s12967-018-1452-4 Received: 10 January 2018 […]

Read the full story

Posted in Journal Articles

European Panel Backs New Nivolumab Dosing Schedules

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended adding the option of a 4-week dosing schedule to the label for nivolumab (Opdivo) for the treatment of patients with advanced melanoma and previously treated renal cell carcinoma (RCC).1

Read the full story

Posted in Melanoma In The News, European Approval

Melanoma Journal Articles for March 2018

CANCER DISCOVERY Research Watch Patients with Desmoplastic Melanoma May Respond to PD-1 Blockade DOI: 10.1158/2159-8290.CD-RW2018-012 Published March 2018 Dove Press Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy Authors Duan X, Mu M, Yan J, Bai L, Zhong L, Zhu Y, Pan H, Zhang M, Shi J Received 30 July 2017 Accepted for publication 7 […]

Read the full story

Posted in Journal Articles

Melanoma Journal Articles for February 2018

Science Translational Medicine Eradication of spontaneous malignancy by local immunotherapy Idit Sagiv-Barfi1, Debra K. Czerwinski1, Shoshana Levy1, Israt S. Alam2, Aaron T. Mayer2, Sanjiv S. Gambhir2 and Ronald Levy1,* Science Translational Medicine  31 Jan 2018: Vol. 10, Issue 426, eaan4488 DOI: 10.1126/scitranslmed.aan4488 Journal of Clinical Oncology Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator’s Choice Chemotherapy in CheckMate 037: […]

Read the full story

Posted in Journal Articles

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories